First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Stock Price Down 0% – Time to Sell?

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was down 0% during trading on Tuesday . The company traded as low as $34.57 and last traded at $34.57. Approximately 2,081 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 8,021 shares. The stock had previously closed at $34.58.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 0.0%

The stock has a market capitalization of $24.20 million, a price-to-earnings ratio of 14.51 and a beta of 0.54. The firm’s fifty day moving average price is $34.29 and its 200 day moving average price is $31.67.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 31st. Shareholders of record on Friday, December 12th were given a $0.1294 dividend. The ex-dividend date of this dividend was Friday, December 12th. This represents a $0.52 dividend on an annualized basis and a yield of 1.5%.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

Institutional investors have recently modified their holdings of the company. NBC Securities Inc. grew its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 33.0% in the fourth quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock valued at $44,000 after purchasing an additional 329 shares in the last quarter. Kestra Advisory Services LLC acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the fourth quarter worth $59,000. Raymond James Financial Inc. acquired a new position in First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter worth $57,000. Steph & Co. acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at approximately $142,000. Finally, Flagship Harbor Advisors LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter worth $205,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.